- Home
- NWTG vs QUCY Comparison
NWTG vs QUCY Comparison
Compare NWTG & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWTG | QUCY |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | Germany |
| Employees | N/A | 13 |
| Industry | Recreational Games/Products/Toys | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 5.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NWTG | QUCY |
|---|---|---|
| Price | $1.17 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.1K | ★ 346.5K |
| Earning Date | 05-14-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $53.21 | $74.34 |
| Revenue Next Year | $40.00 | $171.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.40 |
| 52 Week High | $2.23 | $0.74 |
Technical Indicators
Market Signals| Indicator | NWTG | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 40.96 | 43.76 |
| Support Level | $1.09 | $0.43 |
| Resistance Level | $1.70 | $0.53 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 27.58 | 26.26 |
Price Performance
Historical ComparisonAbout NWTG Newton Golf Company Inc.
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About QUCY Mainz Biomed N.V. Ordinary Shares
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.